A quantitative view on multivalent nanomedicine targeting.
暂无分享,去创建一个
[1] L. Liz‐Marzán,et al. Reversible Control of Protein Corona Formation on Gold Nanoparticles Using Host–Guest Interactions , 2020, ACS nano.
[2] Matthias Müller,et al. Mobility-Based Quantification of Multivalent Virus-Receptor Interactions: New Insights Into Influenza A Virus Binding Mode. , 2019, Nano letters.
[3] M. Dogterom,et al. Solid colloids with surface-mobile linkers , 2015, Journal of physics. Condensed matter : an Institute of Physics journal.
[4] M. Nair,et al. Personalized nanomedicine for CNS diseases. , 2017, Drug discovery today.
[5] K. Dawson,et al. Constructing bifunctional nanoparticles for dual targeting: improved grafting and surface recognition assessment of multiple ligand nanoparticles. , 2016, Nanoscale.
[6] Omid C. Farokhzad,et al. α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. , 2012, ACS nano.
[7] F. Caruso,et al. A few clarifications on MIRIBEL , 2020, Nature Nanotechnology.
[8] M. Heilemann,et al. Subdiffraction-resolution fluorescence imaging with conventional fluorescent probes. , 2008, Angewandte Chemie.
[9] P. Seeman,et al. Dopamine receptors and transporters in Parkinson's disease and schizophrenia , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] P. Kantoff,et al. Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.
[11] Philip S Low,et al. Ligand-Targeted Drug Delivery. , 2017, Chemical reviews.
[12] X. Banquy,et al. Nanoparticle heterogeneity: an emerging structural parameter influencing particle fate in biological media? , 2019, Nanoscale.
[13] B. Liedberg,et al. Direct quantification of surface coverage of antibody in IgG-Gold nanoparticles conjugates. , 2019, Talanta.
[14] Jean-Christophe Leroux,et al. Editorial: Drug Delivery: Too Much Complexity, Not Enough Reproducibility? , 2017, Angewandte Chemie.
[15] P. Dedecker,et al. An introduction to optical super-resolution microscopy for the adventurous biologist , 2018, Methods and applications in fluorescence.
[16] A. Koster,et al. Ultrastructural Imaging of Salmonella–Host Interactions Using Super‐resolution Correlative Light‐Electron Microscopy of Bioorthogonal Pathogens , 2018, Chembiochem : a European journal of chemical biology.
[17] P Bongrand,et al. Cell adhesion. Competition between nonspecific repulsion and specific bonding. , 1984, Biophysical journal.
[18] C. Figdor,et al. Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect , 2017, ACS omega.
[19] C. Wagner,et al. Multivalent Ligand Binding to Cell Membrane Antigens: Defining the Interplay of Affinity, Valency, and Expression Density. , 2018, Journal of the American Chemical Society.
[20] G. MacBeath,et al. Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients. , 2013, The American journal of pathology.
[21] Marie-Lena I. E. Harwardt,et al. Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation , 2020, International journal of molecular sciences.
[22] A. Goepferich,et al. Ligand Density and Linker Length are Critical Factors for Multivalent Nanoparticle-Receptor Interactions. , 2018, ACS applied materials & interfaces.
[23] Delyan R. Hristov,et al. Mapping of Molecular Structure of the Nanoscale Surface in Bionanoparticles. , 2017, Journal of the American Chemical Society.
[24] Mauro Ferrari,et al. Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.
[25] Seungpyo Hong,et al. The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .
[26] Jason T. Duskey,et al. Nanoparticle Ligand Presentation for Targeting Solid Tumors , 2014, AAPS PharmSciTech.
[27] G. Heppner,et al. Tumor heterogeneity: biological implications and therapeutic consequences , 2004, Cancer and Metastasis Reviews.
[28] Ding Ding,et al. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.
[29] Xiaobo Yu,et al. In situ drug-receptor binding kinetics in single cells: a quantitative label-free study of anti-tumor drug resistance , 2014, Scientific Reports.
[30] Vladimir P. Zhdanov,et al. Quantification of Multivalent Interactions by Tracking Single Biological Nanoparticle Mobility on a Lipid Membrane. , 2016, Nano letters.
[31] Giuseppe Battaglia,et al. On the design of precision nanomedicines , 2020, Science Advances.
[32] Melting transition in lipid vesicles functionalised by mobile DNA linkers , 2016 .
[33] L. Albertazzi,et al. Super-resolution Microscopy for Nanomedicine Research , 2019, ACS nano.
[34] D. Frenkel,et al. Designing super selectivity in multivalent nano-particle binding , 2011, Proceedings of the National Academy of Sciences.
[35] D. Fanestil,et al. Interference by lipids in the determination of protein using bicinchoninic acid. , 1986, Analytical biochemistry.
[36] Gaudenz Danuser,et al. Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane , 2017, Scientific Reports.
[37] K. Dawson,et al. Label-free in-flow detection of receptor recognition motifs on the biomolecular corona of nanoparticles. , 2018, Nanoscale.
[38] B. M. Mognetti,et al. Linker-Mediated Phase Behavior of DNA-Coated Colloids , 2019, Physical Review X.
[39] A. Zherdev,et al. Less is More: A Comparison of Antibody-Gold Nanoparticle Conjugates of Different Ratios. , 2017, Bioconjugate chemistry.
[40] K. Landfester,et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona , 2018, Nature Nanotechnology.
[41] K. Dawson,et al. Understanding and Characterizing Functional Properties of Nanoparticles , 2016 .
[42] Christoffer Åberg,et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. , 2015, Nature nanotechnology.
[43] D. Fatouros,et al. Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements. , 2012, Advanced drug delivery reviews.
[44] Gergana Gocheva,et al. A Look at Receptor-Ligand Pairs for Active-Targeting Drug Delivery from Crystallographic and Molecular Dynamics Perspectives. , 2019, Molecular pharmaceutics.
[45] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[46] Xiaoyang Xu,et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.
[47] Thierry Gacoin,et al. Counting the number of proteins coupled to single nanoparticles. , 2007, Journal of the American Chemical Society.
[48] P. Jonkheijm,et al. Weak Multivalent Binding of Influenza Hemagglutinin Nanoparticles at a Sialoglycan-Functionalized Supported Lipid Bilayer , 2019, ACS nano.
[49] J. Crocker,et al. Colloidal interactions and self-assembly using DNA hybridization. , 2005, Physical review letters.
[50] K. S. Gruβmayer,et al. Photons in - numbers out: perspectives in quantitative fluorescence microscopy for in situ protein counting , 2018, Methods and applications in fluorescence.
[51] Rod S. Taylor,et al. Near-field scanning fluorescence microscopy study of ion channel clusters in cardiac myocyte membranes. , 2004, Biophysical journal.
[52] L. Tauzin,et al. Adsorption and Unfolding of a Single Protein Triggers Nanoparticle Aggregation , 2016, ACS nano.
[53] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[54] Mark J. Ratain,et al. Tumour heterogeneity in the clinic , 2013, Nature.
[55] M. Collado,et al. Advances toward More Efficient Targeted Delivery of Nanoparticles in Vivo: Understanding Interactions between Nanoparticles and Cells. , 2017, ACS nano.
[56] M. Nakamoto,et al. Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines , 2007, Clinical Cancer Research.
[57] D. Frenkel,et al. Mobile linkers on DNA-coated colloids: valency without patches. , 2014, Physical review letters.
[58] Robert Langer,et al. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. , 2011, Biomaterials.
[59] T. Jovanović-Talisman,et al. Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2 , 2018, Scientific Reports.
[60] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[61] Fang Huang,et al. Three-Dimensional Single-Molecule Localization Microscopy in Whole-Cell and Tissue Specimens. , 2020, Annual review of biomedical engineering.
[62] D. Peckys,et al. The 2018 correlative microscopy techniques roadmap , 2018, Journal of physics D: Applied physics.
[63] Gur Pines,et al. The ERBB network: at last, cancer therapy meets systems biology , 2012, Nature Reviews Cancer.
[64] J. Driskell,et al. Quantifying Bound and Active Antibodies Conjugated to Gold Nanoparticles: A Comprehensive and Robust Approach To Evaluate Immobilization Chemistry , 2018, ACS omega.
[65] Luigi Calzolai,et al. Determination of the structure and morphology of gold nanoparticle-HSA protein complexes. , 2015, Nanoscale.
[66] Mark M Banaszak Holl,et al. Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation. , 2011, Accounts of chemical research.
[67] E. W. Meijer,et al. A stochastic view on surface inhomogeneity of nanoparticles , 2019, Nature Communications.
[68] Lei Shen,et al. Quantification of Multivalency in Protein-Oligomer-Coated Nanoparticles Targeting Dynamic Membrane Glycan Receptors. , 2018, Langmuir : the ACS journal of surfaces and colloids.
[69] Z. Fayad,et al. Nanoimmunotherapy to treat ischaemic heart disease , 2018, Nature Reviews Cardiology.
[70] Dan Peer,et al. Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.
[71] Serena Mazzucchelli,et al. Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies , 2016, Nature Communications.
[72] Wei Wang,et al. Quantification of epidermal growth factor receptor expression level and binding kinetics on cell surfaces by surface plasmon resonance imaging. , 2015, Analytical chemistry.
[73] Markus Haltmeier,et al. Mapping molecules in scanning far-field fluorescence nanoscopy , 2015, Nature Communications.
[74] Aristidis M. Tsatsakis,et al. Mechanistic understanding of nanoparticles’ interactions with extracellular matrix: the cell and immune system , 2017, Particle and Fibre Toxicology.
[75] P. Cicuta,et al. Kinetics of Nanoparticle-Membrane Adhesion Mediated by Multivalent Interactions. , 2019, Langmuir : the ACS journal of surfaces and colloids.
[76] Gert Storm,et al. The role of liposomes in clinical nanomedicine development. What now? Now what? , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[77] Marina S. Dietz,et al. Optical super-resolution microscopy unravels the molecular composition of functional protein complexes. , 2019, Nanoscale.
[78] Delyan R. Hristov,et al. University of Groningen Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles , 2017 .
[79] A. Perelson,et al. Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: theory and application to HIV treatment. , 2002, Mathematical biosciences.
[80] Nicholas B. Tito,et al. First-order ‘hyper-selective’ binding transition of multivalent particles under force , 2019, Journal of physics. Condensed matter : an Institute of Physics journal.
[81] Antoine M. van Oijen,et al. Quantification of ligand density and stoichiometry on the surface of liposomes using single‐molecule fluorescence imaging , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[82] I. Voets,et al. Super-resolution microscopy as a powerful tool to study complex synthetic materials , 2019, Nature Reviews Chemistry.
[83] R. Kane,et al. Characterization of the diffusion of epidermal growth factor receptor clusters by single particle tracking. , 2013, Biochimica et biophysica acta.
[84] P. Thordarson,et al. Multivalency in Drug Delivery-When Is It Too Much of a Good Thing? , 2019, Bioconjugate chemistry.
[85] Thomas Lars Andresen,et al. Modulating the antibody density changes the uptake and transport at the blood‐brain barrier of both transferrin receptor‐targeted gold nanoparticles and liposomal cargo , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[86] G. Turashvili,et al. Tumor Heterogeneity in Breast Cancer , 2017, Front. Med..
[87] L. Johnston,et al. Imaging nanometer domains of β-adrenergic receptor complexes on the surface of cardiac myocytes , 2005, Nature chemical biology.
[88] R. Netz,et al. Quantitative Prediction of Multivalent Ligand-Receptor Binding Affinities for Influenza, Cholera, and Anthrax Inhibition. , 2018, ACS nano.
[89] C. A. Che Abdullah,et al. A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment , 2017, International journal of nanomedicine.
[90] A. Tkachenko,et al. Kinetic limitations of cooperativity-based drug delivery systems. , 2007, Physical review letters.
[91] David L Rimm,et al. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. , 2003, Cancer research.
[92] A. Popel,et al. Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. , 2011, Experimental cell research.
[93] Stefano Angioletti-Uberti,et al. Theory, simulations and the design of functionalized nanoparticles for biomedical applications: A Soft Matter Perspective , 2017, npj Computational Materials.
[94] N. Gagey-Eilstein,et al. Controlling Ligand Surface Density on Streptavidin-Magnetic Particles by a Simple, Rapid, and Reliable Chemiluminescent Test. , 2018, Bioconjugate chemistry.
[95] C. Lim,et al. Rapid quantification of live cell receptors using bioluminescence in a flow-based microfluidic device. , 2015, Small.
[96] Sang Kyu Kwak,et al. Cloaking nanoparticles with protein corona shield for targeted drug delivery , 2018, Nature Communications.
[97] Iseult Lynch,et al. Best practice in reporting corona studies: Minimum information about Nanomaterial Biocorona Experiments (MINBE). , 2019, Nano today.
[98] D. Frenkel,et al. A general theory of DNA-mediated and other valence-limited colloidal interactions. , 2012, The Journal of chemical physics.
[99] Nicholas B. Tito,et al. Switch-like surface binding of competing multivalent particles , 2016, 1604.04787.
[100] M. Trepel,et al. Differential organization of tonic and chronic B cell antigen receptors in the plasma membrane , 2019, Nature Communications.
[101] Mark Bates,et al. Multicolor Super-Resolution Imaging with Photo-Switchable Fluorescent Probes , 2007, Science.
[102] C. Buske,et al. Super-Resolution Microscopy Unveils Dynamic Heterogeneities in Nanoparticle Protein Corona. , 2017, Small.
[103] Isuru D. Jayasinghe,et al. True Molecular Scale Visualization of Variable Clustering Properties of Ryanodine Receptors , 2018, Cell reports.
[104] P. Decuzzi,et al. Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG-Pairing. , 2020, Nano letters.
[105] M. Heilemann,et al. Receptor-ligand interactions: binding affinities studied by single-molecule and super-resolution microscopy on intact cells. , 2014, Chemphyschem : a European journal of chemical physics and physical chemistry.
[106] P. Lenz,et al. Quantitative Particle Uptake by Cells as Analyzed by Different Methods , 2019, Angewandte Chemie.
[107] T. Park,et al. Diverse Applications of Nanomedicine , 2017, ACS nano.
[108] D. Fletcher,et al. Influenza A virus surface proteins are organized to help penetrate host mucus , 2019, bioRxiv.
[109] R. Weissleder,et al. Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.
[110] M. E. Leunissen,et al. The entropic impact of tethering, multivalency and dynamic recruitment in systems with specific binding groups , 2013 .
[111] J. Storhoff,et al. A DNA-based method for rationally assembling nanoparticles into macroscopic materials , 1996, Nature.
[112] K. Hamad-Schifferli,et al. Physical Properties of Biomolecules at the Nanomaterial Interface. , 2018, The journal of physical chemistry. B.
[113] D. Frenkel,et al. Design Principles for Super Selectivity using Multivalent Interactions , 2016, 1608.01222.
[114] S. Jakobs,et al. STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue , 2014, PloS one.
[115] Youxin Li,et al. Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo , 2018, International journal of nanomedicine.
[116] Lauren E. Marbella,et al. Ligand density quantification on colloidal inorganic nanoparticles. , 2016, The Analyst.
[117] W. Jiskoot,et al. Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[118] G. Roviello,et al. Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer , 2019, Cancers.
[119] Vandana G Abramson,et al. Molecular Heterogeneity of Triple-Negative Breast Cancer , 2014, Current Breast Cancer Reports.
[120] S. Mitragotri,et al. Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm , 2014, ACS nano.
[121] D. Rimm,et al. Automated subcellular localization and quantification of protein expression in tissue microarrays , 2002, Nature Medicine.
[122] Ali Ahmed,et al. Myocardial beta‐1 adrenoceptor down‐regulation in aging and heart failure: implications for beta‐blocker use in older adults with heart failure , 2003, European journal of heart failure.
[123] M. C. Guimarães,et al. Impact of conjugation strategies for targeting of antibodies in gold nanoparticles for ultrasensitive detection of 17β-estradiol , 2019, Scientific Reports.
[124] Isaiah J. Fidler,et al. The challenge of targeting metastasis , 2015, Cancer and Metastasis Reviews.
[125] Nicholas G Welch,et al. Orientation and characterization of immobilized antibodies for improved immunoassays (Review). , 2017, Biointerphases.
[126] L. Albertazzi,et al. Super-resolution Imaging of Structure, Molecular Composition, and Stability of Single Oligonucleotide Polyplexes , 2019, Nano letters.
[127] Bing-he Xu,et al. Targeted therapeutic options and future perspectives for HER2-positive breast cancer , 2019, Signal Transduction and Targeted Therapy.
[128] Edmund J. Crampin,et al. Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.
[129] R. Jain,et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.
[130] P. Imoukhuede,et al. Single-Cell Receptor Quantification of an In Vitro Coculture Angiogenesis Model Reveals VEGFR, NRP1, Tie2, and PDGFR Regulation and Endothelial Heterogeneity , 2019, Processes.
[131] Vito Mennella,et al. Super-Resolution Microscopy: From Single Molecules to Supramolecular Assemblies. , 2015, Trends in cell biology.
[132] Mauro Ferrari,et al. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. , 2010, Trends in biotechnology.
[133] D. Frenkel,et al. Communication: a simple analytical formula for the free energy of ligand-receptor-mediated interactions. , 2012, The Journal of chemical physics.
[134] T. Kiziltepe,et al. Site-specific conjugation of an antibody on a gold nanoparticle surface for one-step diagnosis of prostate specific antigen with dynamic light scattering. , 2017, Nanoscale.
[135] Amanda K. Pearce,et al. Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine. , 2019, Bioconjugate chemistry.
[136] C. van Nostrum,et al. Insights into maleimide‐thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[137] J. Wysolmerski,et al. HER2 signaling regulates HER2 localization and membrane retention , 2017, PloS one.
[138] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[139] S. Mitragotri,et al. Targeting Strategies for Tissue-Specific Drug Delivery , 2020, Cell.
[140] H. Einsele,et al. Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T , 2019, Nature Communications.
[141] R. Kane,et al. A Quantitative Study of the Interaction of Multivalent Ligand-Modified Nanoparticles with Breast Cancer Cells with Tunable Receptor Density. , 2020, ACS nano.
[142] A. J. Tavares,et al. Synthesis of Patient-Specific Nanomaterials. , 2018, Nano letters.
[143] A. V. Chernyshev,et al. Distribution function approach to the study of the kinetics of IgM antibody binding to FcγRIIIb (CD16b) receptors on neutrophils by flow cytometry. , 2011, Journal of theoretical biology.
[144] D. Schaffer,et al. Multivalent ligands to control stem cell behaviour in vitro and in vivo , 2013, Nature nanotechnology.
[145] Jonathan Wang,et al. Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease. , 2017, Biomaterials science.
[146] Hongbin Ji,et al. Mechanistic insights into EGFR membrane clustering revealed by super-resolution imaging. , 2015, Nanoscale.
[147] P. Bolhuis,et al. Rotational diffusion affects the dynamical self-assembly pathways of patchy particles , 2015, Proceedings of the National Academy of Sciences.
[148] R. Schiff,et al. Targeting HER2 for the treatment of breast cancer. , 2015, Annual review of medicine.
[149] P. Cicuta,et al. Membrane Adhesion through Bridging by Multimeric Ligands. , 2017, Langmuir : the ACS journal of surfaces and colloids.
[150] Hans H. Gorris,et al. Advances in Optical Single‐Molecule Detection: En Route to Supersensitive Bioaffinity Assays , 2019, Angewandte Chemie.
[151] Edmund J. Crampin,et al. Revisiting cell-particle association in vitro: A quantitative method to compare particle performance. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[152] Tine Curk,et al. Bonding interactions between ligand-decorated colloidal particles , 2018, Molecular Physics.
[153] M. Sauer,et al. Super-resolution imaging reveals the nanoscale organization of metabotropic glutamate receptors at presynaptic active zones , 2020, Science Advances.
[154] R. Lipowsky,et al. Binding equilibrium and kinetics of membrane-anchored receptors and ligands in cell adhesion: Insights from computational model systems and theory , 2016, Cell adhesion & migration.
[155] A. Mason,et al. Crystal structures of two mutants (K206Q, H207E) of the N‐lobe of human transferrin with increased affinity for iron , 2008, Protein science : a publication of the Protein Society.
[156] P. R. ten Wolde,et al. Generalised expressions for the association and dissociation rate constants of molecules with multiple binding sites , 2018 .
[157] Yunze Yang,et al. Label-free measuring and mapping of binding kinetics of membrane proteins in single living cells. , 2012, Nature chemistry.
[158] Jurriaan Huskens,et al. A model for describing the thermodynamics of multivalent host-guest interactions at interfaces. , 2004, Journal of the American Chemical Society.
[159] R. Jain,et al. Brain Cancer Receptors and Targeting Strategies , 2019, Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis.
[160] R. M. Owen,et al. Selective tumor cell targeting using low-affinity, multivalent interactions. , 2007, ACS chemical biology.
[161] D. Frenkel,et al. Superselective Targeting Using Multivalent Polymers , 2014, Journal of the American Chemical Society.
[162] A C Marques,et al. Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[163] A. Salvati,et al. Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine , 2020, Beilstein journal of nanotechnology.
[164] Pablo Del Pino,et al. Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle-antibody conjugates. , 2011, ACS nano.
[165] Brad J Berron,et al. A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor Cells , 2015, Breast cancer : basic and clinical research.
[166] L. Albertazzi,et al. Nanoscale Mapping Functional Sites on Nanoparticles by Points Accumulation for Imaging in Nanoscale Topography (PAINT). , 2018, ACS nano.
[167] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[168] Shihu Wang,et al. Selectivity of ligand-receptor interactions between nanoparticle and cell surfaces. , 2012, Physical review letters.
[169] Dan Peer,et al. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. , 2017, ACS nano.
[170] Jennifer I. Hare,et al. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.
[171] D. Frenkel,et al. Re-entrant melting as a design principle for DNA-coated colloids. , 2012, Nature materials.
[172] P. Swaan,et al. Endocytic mechanisms for targeted drug delivery. , 2007, Advanced drug delivery reviews.
[173] Min-Yuan Chou,et al. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy , 2015, International journal of nanomedicine.
[174] Alexander A. Chubykin,et al. Three-dimensional nanoscopy of whole cells and tissues with in situ point spread function retrieval , 2020, Nature Methods.
[175] G. I. Bell. Models for the specific adhesion of cells to cells. , 1978, Science.
[176] Kai Ludwig,et al. Size dependence of steric shielding and multivalency effects for globular binding inhibitors. , 2015, Journal of the American Chemical Society.
[177] Peng Yin,et al. Optical visualisation of individual biomolecules in densely packed clusters , 2016 .
[178] Christine Vauthier,et al. Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[179] D. Frenkel,et al. Optimal multivalent targeting of membranes with many distinct receptors , 2017, Proceedings of the National Academy of Sciences.
[180] C. Morasso,et al. HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches. , 2010, Pharmacological research.
[181] L. A. Lane. Physics in nanomedicine: Phenomena governing the in vivo performance of nanoparticles , 2020 .
[182] J. Seoane,et al. The challenge of intratumour heterogeneity in precision medicine , 2014, Journal of internal medicine.
[183] H. Han,et al. Advanced drug delivery system with nanomaterials for personalised medicine to treat breast cancer , 2019, Journal of Drug Delivery Science and Technology.
[184] D. Shaw,et al. A Simple Model of Multivalent Adhesion and Its Application to Influenza Infection , 2016, Biophysical journal.
[185] J. Weaver,et al. Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization techniques , 2014, International journal of nanomedicine.
[186] Wenwan Zhong,et al. High-throughput profiling of nanoparticle-protein interactions by fluorescamine labeling. , 2015, Analytical chemistry.
[187] Bradford G Orr,et al. A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. , 2010, ACS nano.
[188] A S Perelson,et al. Aggregation of cell surface receptors by multivalent ligands , 1982, Journal of mathematical biology.
[189] Johannes B. Woehrstein,et al. Quantitative Super-Resolution Imaging with qPAINT using Transient Binding Analysis , 2016, Nature Methods.
[190] J. Cochran,et al. Targeting ligand-receptor interactions for development of cancer therapeutics. , 2017, Current opinion in chemical biology.
[191] D. Pine,et al. Crystallization of DNA-coated colloids , 2015, Nature Communications.
[192] David J. Harrison,et al. Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence , 2011, Journal of visualized experiments : JoVE.
[193] M. Sliwkowski,et al. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates , 2012, Nature Biotechnology.
[194] Daan Frenkel,et al. Theory and simulation of DNA-coated colloids: a guide for rational design. , 2016, Physical chemistry chemical physics : PCCP.
[195] M. Sauer,et al. Whole-cell imaging of plasma membrane receptors by 3D lattice light-sheet dSTORM , 2020, Nature Communications.
[196] Matthew B Stone,et al. Super-Resolution Microscopy: Shedding Light on the Cellular Plasma Membrane. , 2017, Chemical reviews.
[197] V. Muzykantov,et al. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.
[198] Yao Lu,et al. Recruitment of receptors at supported lipid bilayers promoted by the multivalent binding of ligand-modified unilamellar vesicles† , 2020, Chemical science.
[199] C. Dumontet,et al. Strategies and challenges for the next generation of antibody–drug conjugates , 2017, Nature Reviews Drug Discovery.
[200] N. Iqbal,et al. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications , 2014, Molecular biology international.
[201] W. Mark Saltzman,et al. Nanomedicine gets personal , 2015, Science Translational Medicine.
[202] V. Dravid,et al. Size-Selective Nanoparticle Assembly on Substrates by DNA Density Patterning. , 2016, ACS nano.
[203] Nicholas B. Tito,et al. Multivalent "attacker and guard" strategy for targeting surfaces with low receptor density. , 2018, The Journal of chemical physics.
[204] Alfredo Cesario,et al. Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance , 2016, International journal of molecular sciences.
[205] E. Crampin,et al. An analytical approach for quantifying the influence of nanoparticle polydispersity on cellular delivered dose , 2018, Journal of The Royal Society Interface.
[206] C. Scott,et al. Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy. , 2018, Drug discovery today. Technologies.
[207] Kinam Park,et al. Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[208] E. Jones,et al. Cell guidance ligands, receptors and complexes – orchestrating signalling in time and space , 2019, Current opinion in structural biology.
[209] B. M. Mognetti,et al. Surface-triggered cascade reactions between DNA linkers direct the self-assembly of colloidal crystals of controllable thickness. , 2018, Nanoscale.
[210] Xiaoyuan Chen,et al. Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.
[211] A. Šarić,et al. On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias , 2020, Science Advances.
[212] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[213] Peter Wick,et al. Addition of nanoscaled bioinspired surface features: A revolution for bone related implants and scaffolds? , 2014, Journal of biomedical materials research. Part A.
[214] J. Lippincott-Schwartz,et al. Imaging Intracellular Fluorescent Proteins at Nanometer Resolution , 2006, Science.
[215] A. Perelson,et al. Equilibrium binding of multivalent ligands to cells: effects of cell and receptor density. , 1995, Mathematical biosciences.
[216] Tal Dvir,et al. Nanoparticles targeting the infarcted heart. , 2011, Nano letters.
[217] Jonathan T. C. Liu,et al. Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging , 2015, Physics in medicine and biology.
[218] Kristofer J Thurecht,et al. Recent Advances in the Generation of Antibody–Nanomaterial Conjugates , 2018, Advanced healthcare materials.
[219] Christian Eggeling,et al. STED microscopy reveals crystal colour centres with nanometric resolution. , 2009 .
[220] Raquel Ferreira,et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[221] A. Misra,et al. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells , 2018, Journal of microencapsulation.
[222] A. Johnston,et al. Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency. , 2019, Nano letters.
[223] D. Frenkel,et al. Multivalent Recognition at Fluid Surfaces: The Interplay of Receptor Clustering and Superselectivity. , 2019, Journal of the American Chemical Society.
[224] N. Seeman,et al. Sequential self-assembly of DNA functionalized droplets , 2017, Nature Communications.
[225] Claudio Parolo,et al. Design, preparation, and evaluation of a fixed-orientation antibody/gold-nanoparticle conjugate as an immunosensing label. , 2013, ACS applied materials & interfaces.
[226] B. Różycki,et al. Binding cooperativity of membrane adhesion receptors , 2009, 0906.0462.
[227] T. H. Evers,et al. The influence of covalent immobilization conditions on antibody accessibility on nanoparticles. , 2017, The Analyst.
[228] Kinam Park. The drug delivery field at the inflection point: Time to fight its way out of the egg , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[229] J. Driskell,et al. pH Impacts the Orientation of Antibody Adsorbed onto Gold Nanoparticles. , 2019, Bioconjugate chemistry.
[230] Cristina Fornaguera,et al. Personalized Nanomedicine: A Revolution at the Nanoscale , 2017, Journal of personalized medicine.
[231] K. Dawson,et al. In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry , 2016, Nature Communications.
[232] S. Wilhelm,et al. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. , 2019, Advanced drug delivery reviews.
[233] Joseph L. Goldstein,et al. Recycling receptors: The round-trip itinerary of migrant membrane proteins , 1983, Cell.
[234] Huile Gao,et al. The impact of protein corona on the behavior and targeting capability of nanoparticle‐based delivery system , 2018, International journal of pharmaceutics.
[235] Batakrishna Jana,et al. Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona , 2020, Advanced Therapeutics.
[236] Ming Fang,et al. Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions. , 2010, Macromolecules.
[237] F. Caruso,et al. Particle Targeting in Complex Biological Media , 2018, Advanced healthcare materials.
[238] Bortolo Matteo Mognetti,et al. Bond formation kinetics affects self-assembly directed by ligand-receptor interactions. , 2016, Soft matter.
[239] Abbas Shirinifard,et al. Correlative three-dimensional super-resolution and block-face electron microscopy of whole vitreously frozen cells , 2020, Science.
[240] Susan Hua,et al. Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization , 2018, Front. Pharmacol..
[241] P. Bolhuis,et al. The role of multivalency in the association kinetics of patchy particle complexes. , 2017, The Journal of chemical physics.
[242] T. Behnke,et al. Streptavidin conjugation and quantification—a method evaluation for nanoparticles , 2016, Analytical and Bioanalytical Chemistry.
[243] Alaaldin M. Alkilany,et al. Ligand density on nanoparticles: A parameter with critical impact on nanomedicine. , 2019, Advanced drug delivery reviews.
[244] Morteza Mahmoudi,et al. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.